Related Experiment Video
Updated: Jan 22, 2026

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
Comparative characterization of the HGF/Met and MSP/Ron systems in primary pancreatic adenocarcinoma
Brett R Vanderwerff1, Kevin J Church2, Leen H Kawas2
1Department of School of Molecular Biosciences, Washington State University, Pullman, WA 99164, USA.
Abstract:
Pancreatic cancer is an aggressive disease with a poor prognosis for which current standard chemotherapeutic treatments offer little survival benefit. Receptor tyrosine kinases (RTK)s have garnered interest as therapeutic targets to augment or replace standard chemotherapeutic treatments because of their ability to promote cell growth, migration, and survival in various cancers. Met and Ron, which are homologous RTKs activated by the ligands hepatocyte growth factor (HGF) and macrophage stimulating protein (MSP), respectively, are over-activated and display synergistic malignant effects in several cancers. Despite the homology between Met and Ron, studies that have directly compared the functional outcomes of these systems in any context are limited. To address this, we sought to determine if the HGF/Met and MSP/Ron systems produce overlapping or divergent contributions towards a malignant phenotype by performing a characterization of MSP and HGF driven signaling, behavioral, and transcriptomic responses in a primary pancreatic adenocarcinoma (PAAD) cell line in vitro. The impact of dual Met and Ron expression signatures on the overall survival of PAAD patients was also assessed. We found HGF and MSP both encouraged PAAD cell migration, but only HGF increased proliferation. RNA sequencing revealed that the transcriptomic effects of MSP mimicked a narrow subset of the responses induced by HGF. Analysis of clinical data indicated that the strong prognostic value of Met expression in primary PAAD does not appear to be modulated by Ron expression. The relatively reduced magnitude of MSP-dependent effects on primary PAAD cells are consistent with the limited prognostic value of Ron expression in this cancer when compared to Met. Although HGF and MSP produced a differing breadth of responses in vitro, overlapping pro-cancer signaling, behavioral, and transcriptional effects still point to a potential role for the MSP/Ron system in pancreatic cancer.
Insights
Hepatocyte growth factor (HGF)/Met signaling drives pancreatic cancer cell proliferation and migration, while macrophage stimulating protein (MSP)/Ron signaling primarily impacts migration, suggesting distinct roles for these receptor tyrosine kinases in pancreatic cancer progression.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Signaling
Background:
- Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with poor outcomes.
- Standard chemotherapy offers limited survival benefits for PDAC patients.
- Receptor tyrosine kinases (RTKs), such as Met and Ron, are implicated in cancer progression and are potential therapeutic targets.
Purpose of the Study:
- To compare the functional outcomes of the HGF/Met and MSP/Ron signaling pathways in pancreatic cancer.
- To investigate the in vitro signaling, behavioral, and transcriptomic responses to HGF and MSP in a primary pancreatic adenocarcinoma cell line.
- To assess the impact of Met and Ron expression on patient survival in pancreatic cancer.
Main Methods:
- Characterization of signaling, behavioral, and transcriptomic responses to HGF and MSP in vitro.
- RNA sequencing to analyze transcriptomic alterations.
- Analysis of clinical data to correlate Met and Ron expression with patient survival.
Main Results:
- Both HGF and MSP promoted pancreatic cancer cell migration, but only HGF significantly increased proliferation.
- Transcriptomic analysis revealed that MSP effects partially overlapped with HGF-induced responses.
- Met expression strongly correlated with patient survival, whereas Ron expression showed limited prognostic value.
Conclusions:
- The HGF/Met and MSP/Ron pathways exhibit both overlapping and divergent effects on pancreatic cancer cell behavior.
- The Met pathway appears to be a more significant driver of pancreatic cancer progression and survival than the Ron pathway.
- Despite differing magnitudes of effect, the MSP/Ron system warrants further investigation for its potential role in pancreatic cancer.
Related Concept Videos
Comparative Excretory Systems
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Second Order systems II
First Order Systems
When a first-order system is subjected to a unit-step input, its response is characterized by its transfer function. By applying the Laplace transform of the unit-step input to the transfer function, expanding the...
Second Order systems I
By reinterpreting the system, one can derive the closed-loop transfer function, which...
Comparing the Survival Analysis of Two or More Groups

